Skip to main content
. 2022 Mar 16;13(5):779–785. doi: 10.1021/acsmedchemlett.1c00702

Figure 4.

Figure 4

Continuous inhibition of HDACs 1 and 3 by compounds 4 and 5. (A) (top) Continuous assay progression curves and (bottom) kobs secondary plots (mechanism B) for compound 4. (B) (top) Continuous assay progression curves and (bottom) kobs secondary plots (HDAC1 data fitted to mechanism A and HDAC3 data fitted to mechanism B) for compound 5. Data represent mean ± SEM of individual experiments, with each experiment performed at least twice. See Figure S6 for HDAC2 data and Table 1 for numerical data. *The HDAC3 preparation contained the DAD of NCoR2.